# Eton Pharmaceuticals, Inc.: Form 8-K, filed Apr 27, 2026

- Company: [Eton Pharmaceuticals, Inc.](/companies/eton.md) (CIK 1710340)
- Form: 8-K
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 07:05 ET
- Period: 2026-04-27
- Accession: 0001437749-26-013369
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1710340/000143774926013369/eton20260401_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1710340/000143774926013369/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1710340/000143774926013369/eton20260401_8k.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-013369. Last ingested by Listed: Nov 2, 2026, 07:01 ET. No prices; not investment advice.